News Focus
News Focus
icon url

cheynew

03/06/16 5:31 PM

#257200 RE: Protector #257198

CP,I think in the past you may have mentioned expecting a final washout of retail before the pps starts to climb. I think this has been it. I will feel very badly for those that sell out at very low targets after years of waiting for this investment to mature. I really think this is just a bump in the road and probably good for us to focus on I/O rather than Docetaxel, but very painful nonetheless. Hoping this team shows Wednesday that they have learned something from the aftermath of 9/12 and have a viable plan in place to move forward as rapidly as possible.
icon url

thealias2002

03/06/16 5:55 PM

#257209 RE: Protector #257198

CP,

Is it possible the deal was already in place and the defining factor is how successful sunrise is or isn't at the lookin's?

I.E. X is paid after sunrise completes. 10X is paid if successful sunrise
icon url

vanessapu

03/06/16 6:13 PM

#257211 RE: Protector #257198

I wonder if the timing of article was played with by our enemies.

Just another monkey wrench.
icon url

north40000

03/06/16 7:44 PM

#257223 RE: Protector #257198

CP, uncounted by you are the substantial numbers of shares we added in the last 10 days, mostly @$0.33-36/share, employing some of the STCG/LTCGs arising from OCAT buyout by Astellas. Leave it there for now.
icon url

JJ1223

03/06/16 8:08 PM

#257226 RE: Protector #257198

Those results will be compared to HISTORICAL by a BP (they are not bound to apply the FDA rules) because BP will NOT want to take the risk that a result is GOOD because the CONTROL ARM UNDERPERFORMED. They know the drug has it value if it improves on the historical max. of 10 months and that it is WORTHLESS if it would have beaten a poor 7 months control arm by setting down 10 months.


Great point! investors should read and understand your logic.